Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01380691 · ClinicalTrials.gov registry record · Phase 1
A Study of LY2216684 in Healthy Participants
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT01380691 is a Phase 1 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 28 participants.
The verdict
NCT01380691, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study will evaluate the pharmacodynamic and pharmacokinetic interaction of LY2216684 with alcohol in healthy participants. This study will run approximately for 34 days.
Interventions
- DRUG LY2216684
- DRUG Alcoholic beverage
- DRUG Placebo-matching LY2216684
- DRUG Placebo-matching alcoholic beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-06 |
| Est. Completion | 2011-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01380691
The ClinicalTrials.gov registry entry for NCT01380691 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which LY2216684 is the first listed.
NCT01380691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01380691 about?
NCT01380691 is a clinical study titled "A Study of LY2216684 in Healthy Participants". This study will evaluate the pharmacodynamic and pharmacokinetic interaction of LY2216684 with alcohol in healthy participants. This study will run approximately for 34 days.
What is the current status of trial NCT01380691?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2011-06. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01380691?
The interventions under investigation include: LY2216684 (DRUG), Alcoholic beverage (DRUG), Placebo-matching LY2216684 (DRUG), Placebo-matching alcoholic beverage (DRUG).
Who is sponsoring clinical trial NCT01380691?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.